Skip to content
etf.net

BIS vs PSQ

ProShares UltraShort Nasdaq Biotechnology

BISDNasdaq

ProShares Short QQQ

PSQBNYSE Arca

Overlap

Expense ratio

Same figure. Both funds show the same value, so neither comes out ahead.

BIS0.95%PSQ0.95%

Avg volume · 30D

PSQ 1496.2×the volume

BIS8.68KPSQ13M

10Y return · a year

PSQ +10.0pt

BIS−28.0%PSQ−18.0%

BIS vs PSQ Performance

Oct 29, 2021 – Oct 30, 2026

−68.3%BIS−42.7%PSQ

Oct 29, 2021 to Oct 30, 2026. BIS −68.3%. PSQ −42.7%. Use the arrow keys to read each point.−25%0%25%50%Oct 2021Apr 2024Oct 2026
Expense ratio
BIS 0.95%
PSQ 0.95%
Fund size
BIS $2M
PSQ $611M
1Y total return
BIS −49.7%
PSQ −7.0%, better
Yield (12M)
BIS 5.90%, better
PSQ 3.90%
Holdings
BIS 1
PSQ 4
Avg volume (30D)
BIS 8.68K sh
PSQ 13M sh, better
NAV per share
BIS $10.47
PSQ $26.64
52W range

ETF.net Grade

BIS: Cost 50, Risk 22, Mission not scored, Tradability 36, Holdings not scored, Durability 39. PSQ: Cost 50, Risk 59, Mission 98, Tradability 98, Holdings 55, Durability 72.
Pillar letters and Scores for BIS, PSQ, with each pillar’s weight
PillarBISPSQ
Cost30% weightC50C50
Mission25% weightNot scoredA98
Risk15% weightF22B59Higher
Tradability15% weightD36A98Higher
Holdings10% weightNot scoredB55
Durability5% weightD39A72Higher

Rank among Leveraged Inverse (2x & Other) funds

How we build Categories ›
Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

Same Category. BIS and PSQ are both graded against the same 53 Leveraged Inverse (2x & Other) funds, so their Grades compare head to head.

Leveraged Inverse (2x & Other)⁠

Category · 53 funds
See all 53 ›

PSQ ranks 3rd and BIS 49th of 53 funds in the Leveraged Inverse (2x & Other) Category.

  1. Rank 1BDOGProShares Short Dow30Score 65
  2. Rank 1BSVXYProShares Short VIX Short-Term Futures ETFScore 65
  3. Rank 3BPSQProShares Short QQQScore 64
  4. Rank 4BRWMProShares Short Russell2000Score 63
  5. Rank 32CYXIProShares Short FTSE China 50Score 40
  6. Rank 49DBISProShares UltraShort Nasdaq BiotechnologyScore 39
  7. Rank 50DSDDProShares UltraShort SmallCap600Score 38

Our read on each fund

ETF.net Research

BISDProShares UltraShort Nasdaq Biotechnology

PSQBProShares Short QQQ

In short

BIS The only -2x bet against biotech: BIS aims to deliver twice the inverse of the Nasdaq Biotechnology Index's daily move, then resets the clock every night. A gentler dial than the -3x biotech bear funds, and designed for single-day exposure.

PSQ The plain short on the Nasdaq-100: PSQ aims for -1x the index's daily move, with no leverage multiplier bolted on. It has been running since 2006, making it one of the original one-for-one bear tools.

Stated mandate

BIS The fund seeks daily results, before fees and expenses, equal to approximately negative two times the daily performance of the Nasdaq Biotechnology Index. It is not designed to achieve that target over periods longer than one day.

PSQ The fund is designed to provide -1x exposure to the Nasdaq-100 Index's daily price movement, seeking to benefit when that index declines.

Why people hold it

  • BIS ProShares calls it the only -2x ETF built to move against daily declines in biotech. Where rivals jump straight to -3x, this is the half-step.proshares.com
  • 0.95% net of a waiver through September 30, 2027, near the category median and the same net fee as ProShares stablemates PSQ, DOG and RWM (also waived to that date).
  • Tracks the Nasdaq Biotechnology Index, the cap-weighted Nasdaq-listed biotech and pharma benchmark, rather than the equal-weight small-cap index behind Direxion's -3x biotech pair.proshares.comdirexion.com
  • Live since April 2010, so it has traded through multiple biotech boom-and-bust cycles under the same daily-reset mechanics.
  • PSQ ProShares bills it as the only -1x ETF built to profit when the Nasdaq-100's daily price falls. Sibling QID doubles the dose at -2x; PSQ stays one-for-one.proshares.com
  • 0.95% net of a waiver through September 30, 2027 (0.96% gross), near the category median and the same net fee as -2x QID, also waived through September 30, 2027.
  • Among the most actively traded funds in the bear category, and one of the closest to its stated daily target in a peer group of 50-plus funds.

Worth knowing

  • BIS The prospectus is blunt: it targets -2x for one day and is not designed to hit that over longer periods. Compounding means multi-day results depend on the path.proshares.com
  • Gross expenses run 3.91%; the 0.95% you pay rests on a waiver scheduled through September 30, 2027.
  • One of the smaller, more thinly traded funds in the leveraged-bear group, so spreads can be wider than on headline names like PSQ.
  • PSQ The -1x goal resets daily. Over weeks or months, compounding means results can differ from -1x the index's move across that stretch, especially in choppy markets.sec.gov
  • Cheap for this corner of the market, pricey next to a broad index fund. The fee accrues every day you hold it, hedge or trade.
  • It cuts one way: when the Nasdaq-100 rises on the day, PSQ is designed to fall roughly in step.

Full BIS profile⁠

Full PSQ profile⁠

BIS vs PSQ Holdings

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

BIS vs PSQ Cost

Same expense ratio

$17,869

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • BIS 0.95%

    $17,869

  • PSQ 0.95%

    $17,869

$10,000
30 years

Cost over time

  • BIS 0.95%
  • PSQ 0.95%
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K$20K051015202530BIS $17,869PSQ $17,869

Year by year

YearBISPSQ
10$1,678$1,678
20$6,322$6,322
30$17,869$17,869

Expense ratio

  • 0.95%BIS
  • 0.95%PSQ
  • Middle half of Leveraged Inverse (2x & Other) funds
  • Median 0.95%

BIS 6th cheapest of 53 funds

PSQ 6th cheapest of 53 funds

BIS vs PSQ Dividends

Last 12 months to Oct 30, 2026
Yield (12M)
BIS 5.90%, better
PSQ 3.90%
Payout (12M)
BIS $0.62
PSQ $1.04
Last payment
BIS $0.14
PSQ $0.26
Ex-dividend
BIS Sep 23, 2026
PSQ Sep 23, 2026
Paid on
BIS Sep 29, 2026
PSQ Sep 29, 2026
Frequency
BIS Quarterly
PSQ Quarterly

Distribution history

Per share, 2017 to 2026, same scale for both

BISQuarterly · 14 paymentsAll BIS payments⁠
One bar per payment. 14 payments from 2017 to 2026 YTD. Jun 21, 2023 $0.04; Sep 20, 2023 $0.24; Dec 20, 2023 $0.35; Mar 20, 2024 $0.32; Jun 26, 2024 $0.32; Sep 25, 2024 $0.30; Dec 23, 2024 $0.41; Mar 26, 2025 $0.27; Jun 25, 2025 $0.22; Sep 24, 2025 $0.31; Dec 24, 2025 $0.21; Mar 25, 2026 $0.14; Jun 24, 2026 $0.14; Sep 23, 2026 $0.14. Use the arrow keys to read each point.$0$12017202020232026YTD
PSQQuarterly · 26 paymentsAll PSQ payments⁠
One bar per payment. 26 payments from 2017 to 2026 YTD. Dec 26, 2017 $0.03; Mar 21, 2018 $0.20; Jun 20, 2018 $0.39; Sep 26, 2018 $0.51; Dec 26, 2018 $0.53; Mar 20, 2019 $0.51; Jun 25, 2019 $0.66; Sep 25, 2019 $0.57; Dec 24, 2019 $0.41; Mar 25, 2020 $0.22; Dec 22, 2022 $0.25; Mar 22, 2023 $0.46; Jun 21, 2023 $0.72; Sep 20, 2023 $0.72; Dec 20, 2023 $0.95; Mar 20, 2024 $0.54; Jun 26, 2024 $0.76; Sep 25, 2024 $0.68; Dec 23, 2024 $0.70; Mar 26, 2025 $0.34; Jun 25, 2025 $0.40; Sep 24, 2025 $0.36; Dec 24, 2025 $0.40; Mar 25, 2026 $0.15; Jun 24, 2026 $0.23; Sep 23, 2026 $0.26. Use the arrow keys to read each point.$0$12017202020232026YTD

BIS vs PSQ Risk

Fall from peak · 5 years

  • BIS
  • PSQ
Oct 29, 2021 to Oct 30, 2026. Worst fall: BIS −83.2% · Aug 2026. Use the arrow keys to read each point.−80%−60%−40%−20%0%Oct 2021Apr 2024Oct 2026

Risk facts

VolatilityStd dev, 3 years
BIS 31.5%PSQ 16.8%, better
Return per unit of riskSharpe ratio, 3 years
BIS −1.52PSQ −1.33, better
Worst fallMax drawdown, 5 years
BIS −83.2%PSQ −61.5%, better
Market sensitivityBeta, 5 years
BIS −1.17PSQ −1.18

Popular comparisons

  • BISDvsDOGB

    ProShares UltraShort Nasdaq Biotechnology · ProShares Short Dow30

    Expense ratio
    0.95% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • PSQBvsDOGB

    ProShares Short QQQ · ProShares Short Dow30

    Expense ratio
    0.95% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • BISDvsSVXYB

    ProShares UltraShort Nasdaq Biotechnology · ProShares Short VIX Short-Term Futures ETF

    Expense ratio
    0.95% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • PSQBvsSVXYB

    ProShares Short QQQ · ProShares Short VIX Short-Term Futures ETF

    Expense ratio
    0.95% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • BISDvsRWMB

    ProShares UltraShort Nasdaq Biotechnology · ProShares Short Russell2000

    Expense ratio
    0.95% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • PSQBvsRWMB

    ProShares Short QQQ · ProShares Short Russell2000

    Expense ratio
    0.95% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.